MENU
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives... Show more
Profile
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
107.9M
P/E Ratio
N/A
Total Cash
244.9M
Projected Growth
N/A
Total Debt
65.76M
Revenue
35.58M
Risk (Beta)
3.56
Dividend Yield
N/A
Total Cash/Share
3.45
Total Debt/Equity
N/A
Revenue/Share
0.51 USD as % of share price
Fundamentals
CCCC
Capitalization
108M
P/E Ratio
N/A
Risk (Beta)
3.56
Dividend Yield
N/A
Total Cash
245M
Total Cash/Share
3.45
Total Debt
65.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.51%
Revenue
35.6M
ROE
N/A
Book Value
216M
P/B Ratio
0.50
Cash Flow
N/A
Earnings
-1.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
5.71
Current Revenue Per Employee
47063.64
Dividends Per Share - Security
N/A
EBITDA
-103.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.01
Shares Held By Institutions
275M
Shares Outstanding - Current
71M
Total Liabilities
134M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.139
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com